Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1975 Aug;80(2):189–201.

The influence of prostaglandin endoperoxides on platelet ultrastructure.

J M Gerrard, J G White
PMCID: PMC1912932  PMID: 169697

Abstract

Prostaglandin endoperoxides produced during aggregation of blood platelets are potent promoters of platelet aggregation and the release reaction. The present investigation has studied the effects of prostaglandin endoperoxides produced by platelet microsomes after incubation with arachidonic acid on the ultrastructure of platelets. Prostaglandin endoperoxides caused platelet pseudopod formation and internal transformation associated with a contractile wave within the platelet. The contractile process was similar to that seen following incubation of platelets with collagen or thrombin but was more complete than that seen with 25 muM ADP. Platelet aggregation was more prominent in unstirred samples incubated with the prostaglandin endoperoxides than in samples similarly incubated with 25 muM ADP. Dilatation of the open canalicular system was not a prominent feature except at 45 minutes after addition of the endoperoxides to the platelets, when the platelets appeared to be in a recovery phase. We conclude that the endoperoxides promote platelet stickiness and platelet aggregation by directly or indirectly stimulating the platelet contractile system.

Full text

PDF
193

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carsten M. E. Prostaglandin's part in regulating uterine contraction by transport of calcium. J Reprod Med. 1972 Dec;9(6):277–282. [PubMed] [Google Scholar]
  2. Carsten M. E. Sarcoplasmic reticulum from pregnant bovine uterus; prostaglandins and calcium. Gynecol Invest. 1973;4(2):95–105. doi: 10.1159/000301712. [DOI] [PubMed] [Google Scholar]
  3. Clawson C. C., White J. G. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol. 1971 Nov;65(2):367–380. [PMC free article] [PubMed] [Google Scholar]
  4. Estensen R. D., White J. G. Ultrastructural features on the platelet response to phorbol myristate acetate. Am J Pathol. 1974 Mar;74(3):441–452. [PMC free article] [PubMed] [Google Scholar]
  5. Gerrard J. M., White J. G., Rao G. H. Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol. 1974 Nov;77(2):151–166. [PMC free article] [PubMed] [Google Scholar]
  6. Gerrard J. M., White J. G., Rao G. H., Krivit W., Witkop C. J., Jr Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol. 1975 Apr;29(4):657–665. doi: 10.1111/j.1365-2141.1975.tb02751.x. [DOI] [PubMed] [Google Scholar]
  7. Sedar A. W., Silver M. J., Smith J. B., Ingerman C. M., Kocsis J. J. Ultrastructural changes in human platelets during arachidonic acid-induced aggregation. Blood. 1974 Aug;44(2):177–187. [PubMed] [Google Scholar]
  8. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest. 1974 May;53(5):1468–1472. doi: 10.1172/JCI107695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. White J. G. Fine structural alterations induced in platelets by adenosine diphosphate. Blood. 1968 May;31(5):604–622. [PubMed] [Google Scholar]
  10. White J. G., Rao G. H., Estensen R. D. Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol. 1974 May;75(2):301–314. [PMC free article] [PubMed] [Google Scholar]
  11. White J. G., Rao G. H., Gerrard J. M. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol. 1974 Nov;77(2):135–149. [PMC free article] [PubMed] [Google Scholar]
  12. Willis A. L. An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science. 1974 Jan 25;183(4122):325–327. doi: 10.1126/science.183.4122.325. [DOI] [PubMed] [Google Scholar]
  13. Willis A. L., Kuhn D. C. A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins. 1973 Jul;4(1):127–130. doi: 10.1016/0090-6980(73)90062-2. [DOI] [PubMed] [Google Scholar]
  14. Willis A. L., Vane F. M., Kuhn D. C., Scott C. G., Petrin M. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins. 1974 Dec 25;8(6):453–507. doi: 10.1016/0090-6980(74)90062-8. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES